Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress

ZNF509 is unique among POK family proteins in that four isoforms are generated by alternative splicing. Short ZNF509 (ZNF509S1, -S2 and -S3) isoforms contain one or two out of the seven zinc-fingers contained in long ZNF509 (ZNF509L). Here, we investigated the functions of ZNF509 isoforms in response to DNA damage, showing isoforms to be induced by p53. Intriguingly, to inhibit proliferation of HCT116 and HEK293 cells, we found that ZNF509L activates p21/CDKN1A transcription, while ZNF509S1 induces RB. ZNF509L binds to the p21/CDKN1A promoter either alone or by interacting with MIZ-1 to recruit the co-activator p300 to activate p21/CDKN1A transcription. In contrast, ZNF509S1 binds to the distal RB promoter to interact and interfere with the MIZF repressor, resulting in derepression and transcription of RB. Immunohistochemical analysis revealed that ZNF509 is highly expressed in normal epithelial cells, but was completely repressed in tumor tissues of the colon, lung and skin, indicating a possible role as a tumor suppressor.

[1]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[2]  Y. Qian,et al.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.

[3]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[4]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[5]  R. Treisman,et al.  The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.

[6]  D. Leprince,et al.  The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[7]  K. Kinzler,et al.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.

[8]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[9]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[10]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[11]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[12]  Antony M. Carr,et al.  The evolution of diverse biological responses to DNA damage: insights from yeast and p53 , 2001, Nature Cell Biology.

[13]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[14]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[15]  M. Eilers,et al.  Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter , 2003, Oncogene.

[16]  F. Martelli,et al.  MyoD Stimulates RB Promoter Activity via the CREB/p300 Nuclear Transduction Pathway , 2003, Molecular and Cellular Biology.

[17]  M. Sekimata,et al.  Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. , 2004, Nucleic acids research.

[18]  N. Dyson,et al.  Molecular mechanisms of E2F-dependent activation and pRB-mediated repression , 2004, Journal of Cell Science.

[19]  C. Zahnow,et al.  Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. , 2004, Cancer cell.

[20]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[21]  P. Pandolfi,et al.  Essential role of Plzf in maintenance of spermatogonial stem cells , 2004, Nature Genetics.

[22]  F. Hughes,et al.  Bone morphogenetic protein‐2 induces expression of murine zinc finger transcription factor ZNF450 , 2004, Journal of cellular biochemistry.

[23]  A. Gartel,et al.  Lost in transcription: p21 repression, mechanisms, and consequences. , 2005, Cancer research.

[24]  P. Pandolfi,et al.  Role of the proto-oncogene Pokemon in cellular transformation and ARF repression , 2005, Nature.

[25]  H. Handa,et al.  GABP, HCF‐1 and YY1 are involved in Rb gene expression during myogenesis , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[26]  K. Basso,et al.  BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells , 2005, Nature Immunology.

[27]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[28]  G. Scambia,et al.  RB family members as predictive and prognostic factors in human cancer , 2006, Oncogene.

[29]  B. Amati,et al.  Tip60 in DNA damage response and growth control: many tricks in one HAT. , 2006, Trends in cell biology.

[30]  J. Daniel,et al.  POZ for effect--POZ-ZF transcription factors in cancer and development. , 2006, Trends in cell biology.

[31]  L. Tora,et al.  Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation , 2007, Oncogene.

[32]  J. Costoya.  Functional analysis of the role of POK transcriptional repressors. , 2007, Briefings in functional genomics & proteomics.

[33]  John Varga,et al.  The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis , 2007, Journal of cellular physiology.

[34]  J. Delrow,et al.  Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation , 2008, The EMBO journal.

[35]  P. Pandolfi,et al.  The BTB–zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions , 2008, Nature Immunology.

[36]  B. Jeon,et al.  Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressors* , 2008, Journal of Biological Chemistry.

[37]  D. Koh,et al.  A Novel POK Family Transcription Factor, ZBTB5, Represses Transcription of p21CIP1 Gene* , 2009, The Journal of Biological Chemistry.

[38]  B. O’Malley,et al.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family , 2009, Nature Reviews Cancer.

[39]  B. Jeon,et al.  Proto-oncogene FBI-1 Represses Transcription of p21CIP1 by Inhibition of Transcription Activation by p53 and Sp1* , 2009, Journal of Biological Chemistry.

[40]  Chae-Ok Yun,et al.  ZBTB2, a Novel Master Regulator of the p53 Pathway* , 2009, The Journal of Biological Chemistry.

[41]  Y. Qiu,et al.  A Role of Miz-1 in Gfi-1-Mediated Transcriptional Repression of CDKN1A , 2010, Oncogene.

[42]  Chunhong Ma,et al.  Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. , 2011, Seminars in cancer biology.

[43]  S. Kim,et al.  The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding , 2012, Oncogene.

[44]  K. Nephew,et al.  KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A. , 2012, Cancer research.

[45]  J. Sage.  The retinoblastoma tumor suppressor and stem cell biology. , 2012, Genes & development.

[46]  D. Koh,et al.  Regulation of the Cyclin-dependent Kinase Inhibitor 1A Gene (CDKN1A) by the Repressor BOZF1 through Inhibition of p53 Acetylation and Transcription Factor Sp1 Binding* , 2013, The Journal of Biological Chemistry.

[47]  I. Fariñas,et al.  Transcriptional repression of Bmp2 by p21Waf1/Cip1 links quiescence to neural stem cell maintenance , 2013, Nature Neuroscience.

[48]  D. Koh,et al.  Human Krüppel-related 3 (HKR3) Is a Novel Transcription Activator of Alternate Reading Frame (ARF) Gene* , 2014, The Journal of Biological Chemistry.

[49]  G. Adelmant,et al.  Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis. , 2014, Molecular cell.